Annual Retained Earnings
-$219.25 M
-$16.05 M-7.90%
December 31, 2023
Summary
- As of February 12, 2025, FENC annual retained earnings is -$219.25 million, with the most recent change of -$16.05 million (-7.90%) on December 31, 2023.
- During the last 3 years, FENC annual retained earnings has fallen by -$57.10 million (-35.22%).
- FENC annual retained earnings is now -7189.94% below its all-time high of -$3.01 million, reached on June 30, 2000.
Performance
FENC Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$217.70 M
-$5.74 M-2.71%
September 30, 2024
Summary
- As of February 12, 2025, FENC quarterly retained earnings is -$217.70 million, with the most recent change of -$5.74 million (-2.71%) on September 30, 2024.
- Over the past year, FENC quarterly retained earnings has dropped by -$5.74 million (-2.71%).
- FENC quarterly retained earnings is now -5314.25% below its all-time high of -$4.02 million, reached on December 31, 2000.
Performance
FENC Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
FENC Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.9% | -2.7% |
| 3 y3 years | -35.2% | -4.0% |
| 5 y5 years | -67.0% | -4.0% |
FENC Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.1% | at low | -21.3% | +0.7% |
| 5 y | 5-year | -52.2% | at low | -51.1% | +0.7% |
| alltime | all time | -7189.9% | at low | -5314.3% | +0.7% |
Fennec Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$217.70 M(+2.7%) |
| Jun 2024 | - | -$211.96 M(+2.7%) |
| Mar 2024 | - | -$206.41 M(-5.9%) |
| Dec 2023 | -$219.25 M(+7.9%) | -$219.25 M(+1.2%) |
| Sep 2023 | - | -$216.56 M(+0.9%) |
| Jun 2023 | - | -$214.70 M(+2.6%) |
| Mar 2023 | - | -$209.25 M(+3.0%) |
| Dec 2022 | -$203.20 M(+13.2%) | -$203.20 M(+3.5%) |
| Sep 2022 | - | -$196.34 M(+4.3%) |
| Jun 2022 | - | -$188.25 M(+2.8%) |
| Mar 2022 | - | -$183.18 M(+2.1%) |
| Dec 2021 | -$179.49 M(+10.7%) | -$179.49 M(+2.5%) |
| Sep 2021 | - | -$175.06 M(+2.4%) |
| Jun 2021 | - | -$170.87 M(+2.4%) |
| Mar 2021 | - | -$166.87 M(+2.9%) |
| Dec 2020 | -$162.14 M(+12.6%) | -$162.14 M(+2.0%) |
| Sep 2020 | - | -$158.90 M(+4.1%) |
| Jun 2020 | - | -$152.70 M(+3.3%) |
| Mar 2020 | - | -$147.86 M(+2.7%) |
| Dec 2019 | -$144.03 M(+9.7%) | -$144.03 M(+2.6%) |
| Sep 2019 | - | -$140.42 M(+1.3%) |
| Jun 2019 | - | -$138.61 M(+3.5%) |
| Mar 2019 | - | -$133.88 M(+2.0%) |
| Dec 2018 | -$131.26 M(+8.1%) | -$131.26 M(+2.3%) |
| Sep 2018 | - | -$128.27 M(+2.2%) |
| Jun 2018 | - | -$125.52 M(+2.1%) |
| Mar 2018 | - | -$122.94 M(+1.3%) |
| Dec 2017 | -$121.37 M(+6.2%) | -$121.37 M(+1.9%) |
| Sep 2017 | - | -$119.08 M(+2.0%) |
| Jun 2017 | - | -$116.73 M(+1.4%) |
| Mar 2017 | - | -$115.13 M(+0.7%) |
| Dec 2016 | -$114.32 M(+2.5%) | -$114.32 M(+1.0%) |
| Sep 2016 | - | -$113.18 M(+0.4%) |
| Jun 2016 | - | -$112.68 M(+0.6%) |
| Mar 2016 | - | -$111.95 M(+0.4%) |
| Dec 2015 | -$111.53 M(+0.6%) | -$111.53 M(+0.5%) |
| Sep 2015 | - | -$110.99 M(+0.1%) |
| Jun 2015 | - | -$110.87 M(+0.2%) |
| Mar 2015 | - | -$110.70 M(-0.2%) |
| Dec 2014 | -$110.87 M(+2.0%) | -$110.87 M(-1.2%) |
| Sep 2014 | - | -$112.26 M(-0.3%) |
| Jun 2014 | - | -$112.64 M(+0.7%) |
| Mar 2014 | - | -$111.89 M(+2.9%) |
| Dec 2013 | -$108.70 M(-1.7%) | -$108.70 M(-1.0%) |
| Sep 2013 | - | -$109.81 M(+1.6%) |
| Jun 2013 | - | -$108.04 M(-5.8%) |
| Mar 2013 | - | -$114.65 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | -$110.54 M(+4.9%) | -$110.54 M(+6.3%) |
| Sep 2012 | - | -$104.03 M(+0.7%) |
| Jun 2012 | - | -$103.27 M(+0.6%) |
| Mar 2012 | - | -$102.67 M(-2.6%) |
| Dec 2011 | -$105.38 M(-3.2%) | -$105.38 M(-3.2%) |
| Sep 2011 | - | -$108.89 M(+3.0%) |
| Jun 2011 | - | -$105.74 M(+0.3%) |
| Mar 2011 | - | -$105.40 M(-3.1%) |
| Dec 2010 | -$108.81 M(+7.7%) | -$108.81 M(+6.4%) |
| Sep 2010 | - | -$102.23 M(-1.6%) |
| Jun 2010 | - | -$103.93 M(+2.5%) |
| Mar 2010 | - | -$101.36 M(+0.4%) |
| Dec 2009 | -$100.99 M(+3.1%) | -$100.99 M(-0.2%) |
| Sep 2009 | - | -$101.20 M(+0.0%) |
| Jun 2009 | - | -$101.16 M(+0.9%) |
| Mar 2009 | - | -$100.22 M(+2.3%) |
| Dec 2008 | -$97.98 M(+16.1%) | -$97.98 M(+2.7%) |
| Sep 2008 | - | -$95.37 M(+3.5%) |
| Jun 2008 | - | -$92.13 M(+3.9%) |
| Mar 2008 | - | -$88.68 M(+5.1%) |
| Dec 2007 | -$84.38 M(+18.8%) | -$84.38 M(+3.7%) |
| Sep 2007 | - | -$81.37 M(+4.1%) |
| Jun 2007 | - | -$78.17 M(+4.2%) |
| Mar 2007 | - | -$74.99 M(+5.6%) |
| Dec 2006 | -$71.02 M(+35.5%) | -$71.02 M(+9.1%) |
| Sep 2006 | - | -$65.11 M(+8.3%) |
| Jun 2006 | - | -$60.12 M(+7.5%) |
| Mar 2006 | - | -$55.92 M(+6.7%) |
| Dec 2005 | -$52.40 M(+105.5%) | -$52.40 M(+15.7%) |
| Sep 2005 | - | -$45.30 M(+10.8%) |
| Jun 2005 | - | -$40.90 M(+12.7%) |
| Mar 2005 | - | -$36.27 M(+15.1%) |
| Sep 2004 | - | -$31.52 M(+23.7%) |
| Jun 2004 | -$25.49 M(+53.7%) | -$25.49 M(+10.2%) |
| Mar 2004 | - | -$23.13 M(+9.6%) |
| Dec 2003 | - | -$21.11 M(+16.5%) |
| Sep 2003 | - | -$18.12 M(+9.2%) |
| Jun 2003 | -$16.58 M(+82.0%) | -$16.58 M(+21.8%) |
| Mar 2003 | - | -$13.62 M(+22.4%) |
| Dec 2002 | - | -$11.13 M(+13.4%) |
| Sep 2002 | - | -$9.81 M(+7.7%) |
| Jun 2002 | -$9.11 M(+68.9%) | -$9.11 M(+23.1%) |
| Mar 2002 | - | -$7.40 M(+13.4%) |
| Dec 2001 | - | -$6.52 M(+8.0%) |
| Sep 2001 | - | -$6.04 M(+11.9%) |
| Jun 2001 | -$5.40 M(+79.4%) | -$5.40 M(+34.2%) |
| Dec 2000 | - | -$4.02 M |
| Jun 2000 | -$3.01 M | - |
FAQ
- What is Fennec Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual retained earnings year-on-year change?
- What is Fennec Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly retained earnings year-on-year change?
What is Fennec Pharmaceuticals annual retained earnings?
The current annual retained earnings of FENC is -$219.25 M
What is the all time high annual retained earnings for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual retained earnings is -$3.01 M
What is Fennec Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, FENC annual retained earnings has changed by -$16.05 M (-7.90%)
What is Fennec Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of FENC is -$217.70 M
What is the all time high quarterly retained earnings for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly retained earnings is -$4.02 M
What is Fennec Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, FENC quarterly retained earnings has changed by -$5.74 M (-2.71%)